Articles by tag: exosomes

Pharma-biotics: PDRN and exosomes in K-Beauty 2026

Analysis of the PDRN and exosome boom in Korea: why mass brands are losing, prices 6-10 times lower than procedures, risks and forecasts. Read about the revolution of regenerative care.

CD63-based anti-metastasis drug: truth and risks

Harvard scientists created antibodies to CD63 that stopped melanoma metastasis 100% in mice. We analyze insights, risks, and alternatives. Read more.

Regenerative care instead of anti-aging cosmetics: trend 2026

Exosomes and peptides are displacing anti-wrinkle creams. Find out why regenerative aesthetics is growing by 13% per year and who is making billions. Read the analysis.

Exosomes and NAD+ in Home Care: The Rejuvenation Crisis

We analyze why exosomes and NAD+ in cosmetics are not a breakthrough but a crisis of legitimacy. Learn about the risks, instability, and hidden problems of the market. Read the analysis!

BABOR updates anti-aging care: exosomes and NAD⁺

BABOR launches professional line with exosomes, sirtuins and NAD⁺. Find out how cellular regeneration will change your protocol. Read insights and benefits for clinics.

Biotechnologies in cosmetology: exosomes and peptides

How exosomes and peptides replace hyaluronic acid in aesthetic medicine. Learn about real breakthroughs and marketing myths in skin regeneration. Read the review.

Gene therapy against aging: Russian RNA drugs block RAGE

Scientists from Russia are creating the world's first gene therapeutic drug for aging: a RAGE gene blocker and exosomes against sarcopenia. Learn how the state project promises to restore muscles and prolong active life.